Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D

This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.

Detalles Bibliográficos
Autores principales: Naci, Huseyin, Forrest, Robin, Zhai, Mike, Stofesky, Amanda R., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958521/
https://www.ncbi.nlm.nih.gov/pubmed/36826829
http://dx.doi.org/10.1001/jamahealthforum.2022.5610
Descripción
Sumario:This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.

Ejemplares similares